Physician profile
Maureen E Downing
NPI 1174866248
$729.62
in general payments reported to CMS, 2019-2025
12 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.93 · 2023: $165 · 2024: $224 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $242.09 | 2024-2025 | |
| Hologic Sales and Service, LLC | $190.33 | 2023-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Cytyc Surgical Products, LLC | $129.73 | 2025 | Acessa Provu System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Smith+Nephew, INC. | $27.33 | 2025 | Pico 7 |
| Organon LLC | $25.70 | 2025 | Nexplanon |
| Urgo Medical North America, LLC | $23.02 | 2025 | Urgoclean Ag |
| Exact Sciences Corporation | $18.12 | 2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $16.74 | 2025 | Vistaseal, Evarrest |
| Baxter Healthcare | $15.69 | 2025 | Perclot |
| Sumitomo Pharma America, INC. | $15.42 | 2025 | Myfembree |
| Abbvie INC. | $12.93 | 2021 | |
| Meditrina | $12.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.